Related Experiment Video
Updated: Dec 8, 2025
08:25
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
Published on: September 9, 2020
11.6K
Plasma in Cancer Treatment
Angela Privat-Maldonado1, Annemie Bogaerts1
1PLASMANT, Chemistry Department, University of Antwerp, 2610 Antwerp, Belgium.
Cancers
|September 17, 2020
Summary
Cancer therapies face challenges like toxicity and resistance. New strategies are needed to improve treatment effectiveness and patient outcomes for this widespread disease.
Area of Science:
- Oncology
- Cancer Biology
- Translational Medicine
Background:
- Cancer remains a leading global cause of mortality, necessitating advancements beyond current therapeutic modalities.
- Existing cancer treatments, while improved, are often limited by significant toxicities and the emergence of treatment resistance.
- Addressing these limitations is crucial for enhancing patient survival rates and quality of life.
Discussion:
- Current therapeutic approaches in oncology often exhibit dose-limiting toxicities.
- Acquired resistance to chemotherapy and targeted therapies poses a major clinical challenge, leading to treatment failure.
- Developing novel therapeutic strategies is paramount to overcome these hurdles in cancer care.
Key Insights:
- Significant scientific progress has been made in cancer treatment.
- However, substantial challenges persist, including adverse side effects and drug resistance.
- Further research is essential to develop more effective and safer cancer therapies.
Outlook:
- Future cancer research should focus on innovative treatment modalities to mitigate toxicity.
- Strategies to overcome or prevent therapeutic resistance are critical for long-term patient benefit.
- Continued scientific exploration promises improved outcomes for cancer patients worldwide.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
02:49Cancer Therapies
9.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.6K
02:57Targeted Cancer Therapies
8.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.4K
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
01:27Tumor Immunotherapy
1.4K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.4K
02:53Adaptive Mechanisms in Cancer Cells
6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K